Literature DB >> 17366549

Hepatitis B virus reactivation in a case of Waldenstrom's macroglobulinemia treated with chemotherapy and rituximab despite adefovir prophylaxis.

Yasser Khaled, Amr Hanbali.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17366549     DOI: 10.1002/ajh.20861

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  2 in total

1.  An argument for the universal prophylaxis of hepatitis B infection in patients receiving rituximab: a 7-year institutional experience of hepatitis screening.

Authors:  Christopher Leung; Edward Tsoi; Gareth Burns; William Sievert
Journal:  Oncologist       Date:  2011-04-04

2.  Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients: A Large Cohort Retrospective Study.

Authors:  Liang-Tsai Hsiao; Tzeon-Jye Chiou; Jyh-Pyng Gau; Ching-Fen Yang; Yuan-Bin Yu; Chun-Yu Liu; Jin-Hwang Liu; Po-Min Chen; Cheng-Hwai Tzeng; Yu-Jiun Chan; Muh-Hwa Yang; Yi-Hsiang Huang
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.